PANews September 17 news, the decentralized science platform Bio Protocol announced the completion of a $6.9 million financing round, led by Maelstrom Fund, with participation from Mechanism Capital, Animoca Brands, Presto Labs, and others. This round of financing simultaneously launched Bio V2, introducing on-chain fundraising, a decentralized AI research framework, and the incentive system BioXP. BioAgents, as decentralized science AI agents, support researchers and communities in generating hypotheses, funding experiments, and monetizing discoveries. The first BioAgent was launched in August in collaboration with VitaDAO and Aubrey de Grey's laboratory, generating over $250,000 in research funding and more than 1,000 longevity hypotheses.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
